Literature DB >> 1534375

Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease.

Y Suzuki1, K Hoshi, T Matsuda, Y Mizushima.   

Abstract

Peripheral blood cytotoxic lymphocytes, including gamma delta+ T cells, natural killer (NK) cells, and CD56+ T lymphocytes were investigated by using 2-color flow cytometry in patients with Behçet's disease. The percentage of circulating gamma delta+ T cells among total lymphocytes or among total T cells was significantly increased in patients with Behçet's disease, compared to healthy controls. An increase in circulating gamma delta+ T cells was related to mucocutaneous lesions, but not the HLA-B51. Among gamma delta+ T cells, the number of CD8+ or CD56+ subset was significantly increased in patients with Behçet's disease. Moreover, significant increases of peripheral blood NK cells (CD16+CD56+CD3-, CD2+CD3-, CD8dim+CD3-) and CD56+ T lymphocytes were also observed. Our data suggest that increased circulating gamma delta+ T cells and NK cells may play an important role in the pathogenesis of Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534375

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  32 in total

Review 1.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

3.  Association of Major Histocompatibility Complex Class I Chain-Related Gene A and HLA-B Alleles with Behçet's Disease in Turkey.

Authors:  Nobuko Mizuki; Akira Meguro; Iwai Tohnai; Ahmet Gül; Shigeaki Ohno; Nobuhisa Mizuki
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447

4.  Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.

Authors:  Pablo Guasp; Elena Lorente; Adrian Martín-Esteban; Eilon Barnea; Paolo Romania; Doriana Fruci; JonasJ W Kuiper; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-05-15       Impact factor: 5.911

5.  The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.

Authors:  Pablo Guasp; Eilon Barnea; M Francisca González-Escribano; Anaïs Jiménez-Reinoso; José R Regueiro; Arie Admon; José A López de Castro
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

6.  The distinct expressions of interleukin-15 and interleukin-15 receptor α in Behçet's disease.

Authors:  Jung-Yoon Choe; Hwajeong Lee; Sang Gyung Kim; Min Ji Kim; Sung-Hoon Park; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2013-02-17       Impact factor: 2.631

7.  Gene expression of tumour necrosis factor-alpha (TNF-alpha) and heat-shock protein (HSP) 70 in patients with Behçet's disease.

Authors:  Y Yamakawa; Y Sugita; Y Takahashi; T Yamakawa; S Tanaka; S Nakamura; J Fukushima; S Kawamoto; S Ohno; K Okuda
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  Natural killer cells control a T-helper 1 response in patients with Behçet's disease.

Authors:  Yukie Yamaguchi; Hayato Takahashi; Takashi Satoh; Yuka Okazaki; Nobuhisa Mizuki; Kazuo Takahashi; Zenro Ikezawa; Masataka Kuwana
Journal:  Arthritis Res Ther       Date:  2010-05-11       Impact factor: 5.156

9.  Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with Behçet's disease.

Authors:  Travis Hughes; Filiz Ture-Ozdemir; Fatma Alibaz-Oner; Patrick Coit; Haner Direskeneli; Amr H Sawalha
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

10.  Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients.

Authors:  B Taşçi; H Direskeneli; P Serdaroglu; G Akman-Demir; M Eraksoy; G Saruhan-Direskeneli
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.